The Walden Group is pleased to provide access to its 2025 Year-end Strategic Healthcare M&A Report which includes: Significant M&A Deals by Sector – 2025 Top Deals > $100m in Transaction Value Announced or Closed in 2025 Analysis of More Than 40 Q4 M&A Transactions Click Here to download the Report.
The Walden Group Releases Q3 2025 Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its Q3 Strategic Healthcare M&A Report which includes: Significant M&A Deals by Sector – Q3 2025 Top Deals > $100m in Transaction Value Announced or Closed in Q3 2025 Performance of Leading Healthcare Companies Analysis of More Than 50 M&A Transactions Click …
The Walden Group Releases 2025 Mid-Year Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its 2025 Mid-Year Strategic Healthcare M&A Report which includes: Significant M&A Deals by Sector – H1 2025 Top Deals > $100m in Transaction Value Announced or Closed in H1 2025 Performance of Leading Healthcare Companies Analysis of More Than 50 M&A Transactions …
The Walden Group Represented Hurricane Medical in its Sale to Innovia Medical
The Walden Group is pleased to announce that it represented Hurricane Medical (based in Bradenton, FL), as exclusive M&A adviser, in its sale to Innovia Medical, a global medical device company focused on
specialty surgical products for ENT and ophthalmic procedures, as well as sterile processing systems.
The Walden Group Releases 2024 Year-End Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its 2024 Year-end Strategic Healthcare M&A Report …
The Walden Group Represented RICA Surgical in its Sale to Mastel Surgical, a Pacific Surgical Company
The Walden Group is pleased to announce that it represented RICA Surgical Products, Inc., as investment banker and M&A adviser, in its sale to Mastel Precision Surgical Instruments, Inc., a member of the Pacific Surgical family of companies (based primarily in Canada).
The Walden Group Releases Q2 2024 Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its Q2 Strategic Healthcare M&A Report, which includes: Q2 2024 Market Developments Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q2 2024 Performance of Leading Healthcare Companies Analysis of More Than 45 Q2 M&A …
The Walden Group Releases Q1 2024 Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its Strategic Healthcare M&A Report, which includes: Q1 2024 Market Developments Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q1 2024 Performance of Leading Healthcare Companies Analysis of More Than 45 Q1 M&A Transactions Click …
The Walden Group Releases 2023 Year-End Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its 2023 Year-end Strategic Healthcare M&A Report …
The Walden Group 2024 Medical Device Outsourcing Report
The Walden Group releases its 2024 Medical Device Outsourcing Developments report.
